• Nie Znaleziono Wyników

Wewnątrzczaszkowe wzmocnienie kontrastowe naśladujące krwotok śródczaszkowy po koronarografii

N/A
N/A
Protected

Academic year: 2022

Share "Wewnątrzczaszkowe wzmocnienie kontrastowe naśladujące krwotok śródczaszkowy po koronarografii"

Copied!
3
0
0

Pełen tekst

(1)

www.journals.viamedica.pl/folia_cardiologica

Folia Cardiologica 2017 tom 12, nr 5, strony 467–469 DOI: 10.5603/FC.2017.0087 Copyright © 2017 Via Medica ISSN 2353–7752

PRACA KAZUISTYCZNA

467 Addres for correspondence: Alaa Quisi MD, Department of Cardiology, Adana Numune Training and Research Hospital, Adana, 01170, Turkey, e-mail:

dr.quisi@hotmail.com

Intracranial contrast enhancement mimicking intracranial hemorrhage after coronary angiography

Wewnątrzczaszkowe wzmocnienie kontrastowe naśladujące krwotok śródczaszkowy po koronarografii

Alaa Quisi

Adana Numune Training and Research Hospital, Adana, Turkey

Abstract

A 34-year-old male patient was diagnosed with acute coronary syndrome and referred to our clinic for coronary angio- graphy. After a complex percutaneous coronary intervention he developed non-sustained neurologic symptoms compa- tible with intracranial hemorrhage. Follow-up cranial images revealed rapid clearance of the hyperdensity involvements, consistent with direct neurotoxicity of the contrast agent. The patient’s symptoms resolved and he was discharged without any neurologic sequalea

Key words: contrast agent, neurotoxicity, coronary angiogram

Folia Cardiologica 2017; 12, 5: 467–469

Case report

A 34-year-old male patient was diagnosed with acute coronary syndrome and referred to our clinic for coronary angiography. Baseline cardiac examination on admission was normal and electrocardiography revealed ST segment depressions in the inferolateral leads. Transthoracic echocardiography revealed a regional hypokinesia in the right coronary artery (RCA) territory with an estimated left ventricular ejection fraction of 50%. Laboratory tests were normal expect an elevated level of troponin I (0.4, refe- rence 0.000–0.016 ng/mL). Clopidogrel, acetylsalicylic acid, beta-blocker, statin, angiotensin-converting enzyme, nitrate and heparin was initiated. Coronary angiography revealed a significant atherosclerotic stenoses in the pro- ximal and mid segment of RCA. It was decided to perform percutaneous coronary intervention. After post-dilatation with a non-compliant balloon TIMI 2 flow was observed

and intracoronary bolus of tirofiban followed by intrave- nous infusion was administered. During this complex procedure we approximately injected 400 mL of iohexol (Omnipaque®, GE Healthcare Co., Ireland Cork, Ireland) and 15,000 IU of unfractionated heparin. After 4 hours, the patient complained of drowsiness, severe headache, nausea, and vomiting. The patient’s pupil reflexes were prompt and isocoric, blood pressure was 100/60 mm Hg and heart rate was 80 beats per minute. Complete blood count revealed a hemoglobin level of 14.7 g/dL and plate- let count of 233,000/μL platelets. The prothrombin time (international normalized ratio) was 1.28, the activated partial thromboplastin time was 140.3 seconds, serum creatinine was 0.89 mg/dL, aspartate aminotransferase and alanine aminotransferase were 26 U/L and 50 U/L respectively. Emergent non-contrast brain computed tomography (CT) was performed. Diffuse intracranial hy- perdensity in the transverse sinuses and dura along the

(2)

468

Folia Cardiologica 2017, vol. 12, no. 5

www.journals.viamedica.pl/folia_cardiologica tentorium was observed (Figure 1A, B). We immediately

discontinued acetylsalicylic acid, clopidogrel and tirofiban, and administered intravenous sodium valproate, manni- tol and protamine sulfate. Neurology and neurosurgery consultations were requested. After 4 hours the patient’s symptoms were completely recovered. Control non-contrast brain CTs at the 4th and 24th hours showed a decrease in

the hyperdense involvements (Figure 1C–F). Acetylsa- licylic acid and clopidogrel were reinitiated and patient was discharged on the 4th day without any neurologic or cardiac sequela. On the 1-month visit, he was free of any complaints and brain CT was totally normal.

Contrast-induced neurotoxity (CIN), a very rare compli- cation of contrast agents with an incidence of 0.06% [1]. It Figure 1A, B. Non-contrast brain computed tomography demonstrating diffuse intracranial hyperdensity in the transverse sinuses and dura (arrows) (C, D). Non-contrast brain computed tomography at the 4th hour demonstrating apparent reduction in the hyperdense involvements (arrows) (E, F). Non-contrast brain computed tomography at the 24th hour demonstrating almost total clearance of the contrast agent and near normal brain computed tomography (arrows)

A B

C D

E F

(3)

www.journals.viamedica.pl/folia_cardiologica 469

Alaa Quisi, Contrast-induced neurotoxicity after coronary angiogram can sometimes mimic an acute intracranial hemorrhage.

It is a transient and rapidly reversible entity [2]. Contrast- -induced neurotoxity especially occurs when ionic, and high osmolar agents are used [3]. In general, non-ionic contrast agents have a lower incidence of neurotoxic events than ionic contrast agents. Non-ionic contrast agents, such as iodixanol, can cause transient cortical blindness, confu- sion and amnesia without focal deficits, whereas ionic contrast agents have been reported to cause more severe complications, including seizures and motor and speech deficits. Although it is hard to discriminate between con- trast agent leakage associated neurotoxity and intracranial hemorrhage clinically, hyperdense signal on both T1- and T2-weighted magnetic resonance imaging can be helpful in the diagnosis of intracranial hemorrhage. In this case

non-sustained neurologic symptoms and rapid clearance of the hyperdensity on follow-up images were consistent with direct neurotoxicity of contrast agent. To avoid such adverse effect, contrast agent dosage and concentration should not exceed those recommended by the manufac- turer for coronary angiography.

Funding

The author received no financial support for the case and/

or authorship of this article.

Conflicts of interest

There are no conflicts of interest.

Streszczenie

Mężczyznę w wieku 34 lat z rozpoznaniem ostrego zespołu wieńcowego skierowano do ośrodka autora w celu wykonania koronarografii. Po złożonej przezskórnej interwencji wieńcowej u chorego wystąpiły objawy neurologiczne sugerujące krwotok wewnątrzczaszkowy. Kontrolne obrazowanie czaszki ujawniło szybką eliminację ognisk hiperdensyjnych świad- czącą o bezpośredniej toksyczności środka cieniującego. Objawy ustąpiły całkowicie bez żadnych powikłań neurologicz- nych i chorego wypisano ze szpitala.

Słowa kluczowe: środek kontrastowy, neurotoksyczność, angiogram wieńcowy

Folia Cardiologica 2017; 12, 5: 467–469

References

1. Fanning NF. Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling. A case re- port and review of the literature. Interv Neuroradiol. 2012; 18(1):

33–41, doi: 10.1177/159101991201800105, indexed in Pub- med: 22440599.

2. Sharp S, Stone J, Beach R. Contrast agent neurotoxicity presenting as subarachnoid hemorrhage. Neurology. 1999; 52(7): 1503–1505, indexed in Pubmed: 10227646.

3. Torvik A, Walday P. Neurotoxicity of water-soluble contrast media. Acta Radiol Suppl. 1995; 399: 221–229, indexed in Pubmed: 8610520.

Cytaty

Powiązane dokumenty

III,5kolanowe, skokowe, śródstopno-paliczkowe, skroniowo-żuchwowe, +–+zapalenie zatok, oskrzeli, dróg moczowych częste nawroty, synowektomia artroskopowa stawu skokowego prawego,

V roce 2008 Spolenost Tramwaje ?l<skie S.A jako hlavní píjemce spolu se spoleností Tyskie Linie Trolejbusowe Sp. z o.o, partnerem projektu, podala žádost o

When the MRS results (subgroups and total score) of women in the surgical menopause group were clas- sified as mild and severe, no statistically significant re- lationship was

Ze względu na swój specyficzny charakter guzy neuroendokrynne przewodu pokarmowego i trzustki (gastroenteropancreatic neuroendocrine tumors – GEP-NET) znajdują się w

Szczególną sytuacją podczas leczenia czynni- kiem VIII jest pojawienie się inhibitora czynnika krzepnięcia; dotyczy to 15–30% pacjentów chorych na ciężką hemofilię

W niniejszej pracy przedstawiono przypadek 49-letniej pacjentki z zespołem Sneddona pozostającej pod obser- wacją kliniki autorów od 16 lat, czyli od 1989 roku, u której

Key words: left ventricular pacing, cardiac resynchronization, biventricular pacing, ventricular fusion, electrocardiography, heart failure, anodal capture,

During simultaneous biventricular pacing from the posterior or posterolateral coronary vein with the RV lead in the outflow tract, the paced QRS in lead V1 is often negative and